MetaADEDB 2.0 @ LMMD
Hydroxyethyl Starch Derivatives
(CWSZBVAUYPTXTG-UHFFFAOYSA-N)
Structure
SMILES
OCCOC1C(OC2C(COC3OC(CO)C(C(C3O)O)OC)OC(C(C2O)O)OC2C(CO)OC(C(C2O)O)C)OC(C(C1O)OC)CO
Molecular Formula:
C29H52O21
Molecular Weight:
736.711
Log P:
-7.3539
Hydrogen Bond Acceptor:
21
Hydrogen Bond Donor:
11
TPSA:
314.83
CAS Number(s):
9004-62-0
Synonym(s)
1.
Hydroxyethyl Starch Derivatives
2.
Hetastarch
3.
Elohes
4.
HAES-steril
5.
Hemohes
6.
Hespan
7.
Hydroxyethyl Starch (130 KD-0.4 Substitution)
8.
Hydroxyethyl Starch 130-0.4
9.
Hydroxyethylated Starches
10.
Pentafraction
11.
Pentaspan
12.
Pentastarch
13.
Plasmasteril
14.
Starches, 2-Hydroxyethyl
15.
2-Hydroxyethyl Starches
16.
Derivatives, Hydroxyethyl Starch
17.
Hydroxyethyl Starch 130 0.4
18.
Starch Derivatives, Hydroxyethyl
19.
Starches, 2 Hydroxyethyl
20.
Starches, Hydroxyethylated
External Link(s)
MeSHD006895
PubChem Compound24846132
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ChillsFAERS: 4SIDER
US FAERS
2PruritusFAERS: 4SIDER
US FAERS
3Anaphylactic shockFAERS: 3SIDER
US FAERS
4CyanosisFAERS: 3US FAERS
5Drug ineffectiveFAERS: 3US FAERS
6HypersensitivityFAERS: 3SIDER
US FAERS
7Product complaintFAERS: 3US FAERS
8Blood creatinine increasedFAERS: 2US FAERS
9Blood urea increasedFAERS: 2US FAERS
10Chest discomfortFAERS: 2US FAERS
11Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
12ExtravasationFAERS: 2US FAERS
13Medication ErrorFAERS: 2US FAERS
14UrticariaFAERS: 2SIDER
US FAERS
15Anaphylactoid ReactionFAERS: 1SIDER
US FAERS
16AngioedemaFAERS: 1SIDER
US FAERS
17Blood creatinine decreasedFAERS: 1US FAERS
18Blood potassium increasedFAERS: 1US FAERS
19Blood urine presentFAERS: 1US FAERS
20BradycardiaFAERS: 1SIDER
US FAERS
21BronchospasmFAERS: 1SIDER
US FAERS
22Cardiac ArrestFAERS: 1SIDER
US FAERS
23Drug administration errorFAERS: 1US FAERS
24DysphoniaFAERS: 1US FAERS
25ErythemaFAERS: 1US FAERS
26FlushingFAERS: 1
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
27HypotensionFAERS: 1
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
28Intercepted medication errorFAERS: 1US FAERS
29MalaiseFAERS: 1US FAERS
30NasopharyngitisFAERS: 1US FAERS
31Nephrotic SyndromeFAERS: 1US FAERS
32OliguriaFAERS: 1US FAERS
33PalpitationsFAERS: 1US FAERS
34Pharmaceutical product complaintFAERS: 1US FAERS
35Product dispensing errorFAERS: 1US FAERS
36Product expiration date issueFAERS: 1US FAERS
37Product label confusionFAERS: 1US FAERS
38Product lot number issueFAERS: 1US FAERS
39Product packaging issueFAERS: 1US FAERS
40SepsisFAERS: 1SIDER
US FAERS
41TachyarrhythmiaFAERS: 1US FAERS
42TachycardiaFAERS: 1SIDER
US FAERS
43TremorFAERS: 1US FAERS
44VomitingFAERS: 1SIDER
US FAERS
45Wrong drug administeredFAERS: 1US FAERS
46AgitationSIDER
47BlindnessCanada Vigilance: 1Canada Vigilance
48Blood and lymphatic system disordersSIDER
49Chest PainSIDER
50DermatitisSIDER
51Erythema MultiformeSIDER
52Factor VIII DeficiencySIDER
53HeadacheSIDER
54Influenza-like symptomsSIDER
55Metabolic acidosisSIDER
56Musculoskeletal discomfortSIDER
57MyalgiaSIDER
58Myocardial InfarctionCanada Vigilance: 1Canada Vigilance
59PancreatitisSIDER
60SneezingSIDER
61StridorSIDER
62ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
63Ventricular FibrillationSIDER
64WheezingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.